View More
Read my thoughts on the importance of using combination chemoimmunotherapy as first-line treatment for extensive-stage SCLC.
Taofeek K. Owonikoko, MD, PhD
Released: October 13, 2020
Do you know about the key clinical trials in relapsed extensive-stage small-cell lung cancer presented at WCLC 2020?
Nicolas Girard, MD, PhD
Released: March 1, 2021
Read this expert commentary for an overview of our new treatment decision support tool for extensive-stage small-cell lung cancer, which provides treatment recommendations from 5 lung cancer experts for your patients with newly diagnosed and relapsed/refractory disease.
Anne Chiang, MD, PhD
Released: May 26, 2021
Contact Clinical Care Options
For customer support please email: customersupport@clinicaloptions.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.